Abiopharma

🔍 MCINERNEY RYAN (Director)

Company: VISA INC. (V)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 5,875 shares of Class A Common Stock at $134.76 per share (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,049.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,875 shares of Class A Common Stock at $379.65 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,174.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: Ryan and Angela McInerney Trust | shares_owned_after: 265,168.00
• Sold 5,875 shares of Employee Stock Option (Right to Buy) at $134.76 per share (Derivative)
  Date: 2026-09-01 | Code: M | Expires: 2028-11-19 | equity_swap_involved: 0 | shares_owned_after: 58,749.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This transaction was made pursuant to a Rule 10b5-1 trading plan dated May 22, 2026 adopted by the reporting person.
• F2: Options vest in three equal installments on each of the first three anniversaries of the date of the grant, subject to earlier vesting in full in limited circumstances as specified in the award agreement. The option was granted on November 19, 2018.